Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University

Launched by NESREEN ABDEL FATTAH ABDULLAH SHEHATA · Jun 13, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new approach to help women with a condition called placenta accreta, where the placenta attaches too deeply into the uterus. The study is testing a method that involves modified uterine artery ligation and myometrial compression, which are techniques aimed at improving the health outcomes for women facing this issue. The trial is currently looking for female participants who are more than 28 weeks pregnant, have been diagnosed with placenta previa (a condition where the placenta covers the cervix), and are in stable health with little to no vaginal bleeding.

If you or someone you know qualifies and decides to participate, you can expect to receive close monitoring throughout the trial. It’s important to note that women with significant vaginal bleeding or certain medical conditions will not be eligible to join. Participating in this study could contribute to better understanding and management of placenta accreta, potentially benefiting many women in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Gestational age more than 28 weeks as determined by LMP and ultrasound.
• • Placenta previa as confirmed by ultrasound.
• • Clinically stable with no or mild vaginal bleeding.
• • No evidence of fetal compromise.
• • Patient consent.
• Exclusion Criteria:
• • Vaginal bleeding
• • Medical disorders